An Ethical Debate Genetic testing for familial hypertrophic cardiomyopathy in newborn infants: Knowledge of risk allows adaptationBMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6983.859 (Published 01 April 1995) Cite this as: BMJ 1995;310:859
- Leanne Grigg, acting director of cardiologya
- a Royal Melbourne Hospital, Parkville, Victoria 3050, Australia
Familial hypertrophic cardiomyopathy has usually been diagnosed on the basis of physical examination, electrocardiography, and echocardiography. Echocardiography has advantages since the technique is non-invasive and relatively cheap. However, making an accurate diagnosis can be particularly difficult in children, who may not develop cardiac hypertrophy until adulthood.
As hypertrophic cardiomyopathy may cause sudden death in young people, and indeed is the commonest recognised caused of sudden death in competitive athletes, it is important to diagnose the condition early. There is as …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial